BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25019373)

  • 1. NIR-triggered drug release from switchable rotaxane-functionalized silica-covered Au nanorods.
    Li M; Yan H; Teh C; Korzh V; Zhao Y
    Chem Commun (Camb); 2014 Sep; 50(68):9745-8. PubMed ID: 25019373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold nanorods coated with mesoporous silica shell as drug delivery system for remote near infrared light-activated release and potential phototherapy.
    Liu J; Detrembleur C; De Pauw-Gillet MC; Mornet S; Jérôme C; Duguet E
    Small; 2015 May; 11(19):2323-32. PubMed ID: 25580816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIR-triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene-modified mesoporous silica.
    Liu J; Bu W; Pan L; Shi J
    Angew Chem Int Ed Engl; 2013 Apr; 52(16):4375-9. PubMed ID: 23495013
    [No Abstract]   [Full Text] [Related]  

  • 4. NIR-enhanced drug release from porous Au/SiO2 nanoparticles.
    Yagüe C; Arruebo M; Santamaria J
    Chem Commun (Camb); 2010 Oct; 46(40):7513-5. PubMed ID: 20830418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of oligonucleotide-gated silica shell-coated Fe₃O₄-Au core-shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform.
    Li WP; Liao PY; Su CH; Yeh CS
    J Am Chem Soc; 2014 Jul; 136(28):10062-75. PubMed ID: 24953310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIR-Controlled Treatment of Multidrug-Resistant Tumor Cells by Mesoporous Silica Capsules Containing Gold Nanorods and Doxorubicin.
    Yang X; Li M; Liang J; Hou X; He X; Wang K
    ACS Appl Mater Interfaces; 2021 Apr; 13(13):14894-14910. PubMed ID: 33769025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
    Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-triggered reversible assemblies of azobenzene-containing amphiphilic copolymer with β-cyclodextrin-modified hollow mesoporous silica nanoparticles for controlled drug release.
    Mei X; Yang S; Chen D; Li N; Li H; Xu Q; Ge J; Lu J
    Chem Commun (Camb); 2012 Oct; 48(80):10010-2. PubMed ID: 22946093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver nanoparticle gated, mesoporous silica coated gold nanorods (AuNR@MS@AgNPs): low premature release and multifunctional cancer theranostic platform.
    Zhang Z; Liu C; Bai J; Wu C; Xiao Y; Li Y; Zheng J; Yang R; Tan W
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6211-9. PubMed ID: 25707533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold nanorods with phase-changing polymer corona for remotely near-infrared-triggered drug release.
    Liu J; Detrembleur C; Grignard B; De Pauw-Gillet MC; Mornet S; Treguer-Delapierre M; Petit Y; Jérôme C; Duguet E
    Chem Asian J; 2014 Jan; 9(1):275-88. PubMed ID: 24347074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyapatite/mesoporous silica coated gold nanorods with improved degradability as a multi-responsive drug delivery platform.
    Song Z; Liu Y; Shi J; Ma T; Zhang Z; Ma H; Cao S
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():90-98. PubMed ID: 29208292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A NIR light-triggered drug delivery system using core-shell gold nanostars-mesoporous silica nanoparticles based on multiphoton absorption photo-dissociation of 2-nitrobenzyl PEG.
    Hernández-Montoto A; Gorbe M; Llopis-Lorente A; Terrés JM; Montes R; Cao-Milán R; Díaz de Greñu B; Alfonso M; Orzaez M; Marcos MD; Martínez-Máñez R; Sancenón F
    Chem Commun (Camb); 2019 Aug; 55(61):9039-9042. PubMed ID: 31292589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yolk-shell structured Au nanorods@mesoporous silica for gas bubble driven drug release upon near-infrared light irradiation.
    Lv W; Xia H; Zou L; Zhao M; Yang T; Jiang J; Chen Z; Liu S; Zhao Q
    Nanomedicine; 2021 Feb; 32():102326. PubMed ID: 33166666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared light triggered release of molecules from supramolecular hydrogel-nanorod composites.
    Highley CB; Kim M; Lee D; Burdick JA
    Nanomedicine (Lond); 2016 Jun; 11(12):1579-90. PubMed ID: 27176049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-shell-shell nanorods for controlled release of silver that can serve as a nanoheater for photothermal treatment on bacteria.
    Hu B; Wang N; Han L; Chen ML; Wang JH
    Acta Biomater; 2015 Jan; 11():511-9. PubMed ID: 25219350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silica nanotubes decorated by pH-responsive diblock copolymers for controlled drug release.
    Zhou J; Zhang W; Hong C; Pan C
    ACS Appl Mater Interfaces; 2015 Feb; 7(6):3618-25. PubMed ID: 25625307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold nanorod-cored biodegradable micelles as a robust and remotely controllable doxorubicin release system for potent inhibition of drug-sensitive and -resistant cancer cells.
    Zhong Y; Wang C; Cheng L; Meng F; Zhong Z; Liu Z
    Biomacromolecules; 2013 Jul; 14(7):2411-9. PubMed ID: 23701318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery.
    Park SB; Joo YH; Kim H; Ryu W; Park YI
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():64-73. PubMed ID: 25746247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.